ArticleJTO clinical and research reports2025

Combination Therapy With MET Tyrosine Kinase Inhibitor and EGFR Tyrosine Kinase Inhibitor in Patients With MET-Overexpressed EGFR-Mutant Lung Adenocarcinoma.

Jia-Jun Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.